Guggenheim initiates coverage of Entera Bio with Buy rating, $11 price target
Guggenheim initiated coverage on Entera Bio's stock with a rating of Buy and a price target of $11.00.The price target implies an upside of 292.9% from the Sep 24 close of $2.80.Key takeaways from the analyst noteInnovative Delivery Platform: Entera Bio's N-Tab peptide platform enables the oral del…